CLVT icon

Clarivate

4.98 USD
+0.08
1.63%
At close Dec 20, 4:00 PM EST
After hours
4.98
+0.00
0.00%
1 day
1.63%
5 days
-7.95%
1 month
-2.16%
3 months
-28.24%
6 months
-8.96%
Year to date
-45.15%
1 year
-44.23%
5 years
-71.18%
10 years
-63.06%
 

About: Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas while Europe, Middle East, and Africa account for around a quarter.

Employees: 12,000

0
Funds holding %
of 6,809 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

24% more capital invested

Capital invested by funds: $3.63B [Q2] → $4.49B (+$862M) [Q3]

9% more funds holding in top 10

Funds holding in top 10: 11 [Q2] → 12 (+1) [Q3]

6% more call options, than puts

Call options by funds: $120K | Put options by funds: $113K

0.75% less ownership

Funds ownership: 88.05% [Q2] → 87.3% (-0.75%) [Q3]

1% less repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 67

3% less funds holding

Funds holding: 206 [Q2] → 199 (-7) [Q3]

18% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 39

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$4
20%
downside
Avg. target
$5
0%
upside
High target
$6
20%
upside

2 analyst ratings

positive
0%
neutral
50%
negative
50%
RBC Capital
Ashish Sabadra
65% 1-year accuracy
33 / 51 met price target
20%upside
$6
Sector Perform
Maintained
7 Nov 2024
Barclays
Manav Patnaik
59% 1-year accuracy
23 / 39 met price target
20%downside
$4
Underweight
Maintained
7 Nov 2024

Financial journalist opinion

Based on 5 articles about CLVT published over the past 30 days

Neutral
PRNewsWire
5 days ago
Clarivate Announces New $500 Million Share Repurchase Authorization
LONDON , Dec. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today announced that its Board of Directors (the "Board") authorized a new share repurchase program of up to $500 million of the Company's outstanding ordinary shares through open-market purchases for a period of two years, from January 1, 2025 through December 31, 2026. The new share repurchase program replaces the current share repurchase program which terminates December 31, 2024, under which the Company repurchased $300 million of ordinary shares, including $200 million during the third and fourth quarters of 2024.
Clarivate Announces New $500 Million Share Repurchase Authorization
Neutral
PRNewsWire
1 week ago
Clarivate Launches AI-Powered Patent Search Solution in Derwent
Faster and more relevant results to empower critical IP decision-making LONDON , Dec. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of AI Search in Derwent™. Combining artificial intelligence (AI) with the premier source of global patent data, Derwent World Patents Index (DWPI)™, this solution will enable intellectual property (IP) professionals to make reliable innovation decisions by finding more relevant patents in less time.
Clarivate Launches AI-Powered Patent Search Solution in Derwent
Positive
MarketBeat
1 week ago
Bargains Galore? 3 Stocks With Insider Buying in the Millions
It's widely believed that insiders know how well a company is operating. Therefore, when insiders are actively buying their stock, it is assumed they must know something that's motivating them to buy shares.
Bargains Galore? 3 Stocks With Insider Buying in the Millions
Neutral
PRNewsWire
3 weeks ago
Clarivate and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research Fronts
Revealing highly active specialties in sciences and social sciences LONDON , Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, and the Chinese Academy of Sciences (CAS) today released 2024 Research Fronts™, identifying the most dynamic and rapidly growing specialties in sciences and social sciences. This marks the eleventh annual collaboration between the two organizations, with the report launched at a ceremony held in Beijing today.
Clarivate and the Chinese Academy of Sciences Release Annual Collaborative Report to Identify 125 Research Fronts
Neutral
PRNewsWire
3 weeks ago
Daikin Selects IPfolio from Clarivate
Enhancing operational efficiency for leading air conditioner manufacturer LONDON , Nov. 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Daikin Industries, Ltd. (Daikin) has selected IPfolio™ from Clarivate.
Daikin Selects IPfolio from Clarivate
Neutral
PRNewsWire
1 month ago
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON , Nov. 21, 2024 /PRNewswire/ --  BioWorld ™ published by  Clarivate Plc  (NYSE:CLVT), a leading global provider of transformative intelligence, has launched its new special series, 'Healing the Health Divide. ' This seven-part series sheds light on the persistent disparities in women's health research, funding, and treatment.
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment in New Special Series
Neutral
PRNewsWire
1 month ago
Clarivate Reveals Highly Cited Researchers 2024 List
Prioritizing research integrity with enhanced filters to address publication and citation manipulation LONDON , Nov. 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2024 list of Highly Cited Researchers™ – influential researchers at universities, research institutes and commercial organizations around the world who have demonstrated significant and broad influence in their field(s) of research. Analysts at the Institute for Scientific Information (ISI)™ have recognized 6,636 Highly Cited Researchers in 2024 from more than 1,200 institutions in 59 nations and regions.
Clarivate Reveals Highly Cited Researchers 2024 List
Neutral
PRNewsWire
1 month ago
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence
New report analyses Mainland China's transformation into a global biopharma powerhouse, with key insights for international stakeholders LONDON , Nov. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the release of a new report, A Decade of Innovation, A Decade to Come . Over the past decade, Mainland China's biopharmaceutical sector has rapidly advanced to become a global leader in innovation, ranking among the top three for initial drug launches.
New Report from Clarivate and Healthcare Executive Explores Mainland China's Biopharma Revolution and Increasing Global Influence
Neutral
PRNewsWire
1 month ago
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners
Recognizing Roper St. Francis Healthcare, Bon Secours Mercy Health, and Bronson Methodist Hospital for excellence in Physician and Hospital Groups LONDON , Nov. 13, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the 2023 winners of the Clarivate Healthcare Business Insights™ annual Revenue Cycle Awards. Now in its 12th year, the Revenue Cycle Awards recognize U.S.-based healthcare organizations for exceptional performance on revenue cycle KPIs, based on data from their most recent and preceding full fiscal years.
Clarivate Healthcare Business Insights Unveils 2023 Revenue Cycle Award Winners
Neutral
PRNewsWire
1 month ago
Clarivate Publishes 2023 Sustainability Report
LONDON , Nov. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has today published its fourth annual sustainability report, showcasing its commitment to sustainability and the United Nations Sustainable Development Goals (SDGs). In 2023, Clarivate was shortlisted for the SDG Pioneer Award at the Thomson Reuters Responsible Business Awards.
Clarivate Publishes 2023 Sustainability Report
Charts implemented using Lightweight Charts™